Contact
Professor, Faculty of Medicine & Dentistry - Oncology Dept
- msawyer@ualberta.ca
- Phone
- (780) 432-8248
- Address
-
Cross Cancer Institute
11560 University AvenueEdmonton ABT6G 1Z2
Overview
Area of Study / Keywords
About
Academic InterestsTranslational cancer research, Phase I studies/Drug Development, Clinical Pharmacology of Anticancer Drugs, and Pharmacogenetics
Clinical Practice
Gastrointestinal Malignancies, Neuroendocrine Tumors, Phase I Studies
Research
Clinical Trials Research:
My interest in clinical trials is focused on gastrointestinal malignancies and neuroendocrine tutors. Along with
Fundamental/Translational Research:
My focus is on
Featured Publications
Annual Meeting of American Society of Clinical Oncology. 2022 June; 10.1200/JCO.2022.40.16_suppl.3573
Cancer Res (2022) 82 (12_Supplement): CT006. 2022 June; 10.1158/1538-7445.AM2022-CT006
Annual Meeting of the American Society of Clinical Oncology. 2022 June; 10.1200/JCO.2022.40.16_suppl.3614
Abdel-Rahman O., Pham T.M., Pokhrel A., Ruether D., Sawyer M.B.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2022 May; 45 (5):208-214 10.1097/COC.0000000000000906
Youn S., Eurich D.T., McCall M., Walker J., Smylie M., Sawyer M.B.
CLINICAL NUTRITION. 2022 May; 41 (5):1066-1072 10.1016/j.clnu.2022.03.001
Giani J., Chambers C.R., Sawyer M.B.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022 March; 28 (2):457-461 10.1177/10781552211038031
Youn S., Jogiat U., Baracos V.E., McCall M., Eurich D.T., Sawyer M.B.
Clinical Nutrition ESPEN. 2021 October; 45 10.1016/j.clnesp.2021.06.029
Joy A.A., Vos L.J., Pituskin E., Cook S.F., Bies R.R., Vlahadamis A., King K., Basi S.K., Meza-Junco J., Mackey J.R., Stanislaus A., Damaraju V.L., Damaraju S., Sawyer M.B.
Clinical Breast Cancer. 2021 October; 21 (5):e584-e593 10.1016/j.clbc.2021.03.001
Youn S., Chen A., Ha V., Chambers C., Eurich D.T., McCall M., Sawyer M.B.
CLINICAL NUTRITION. 2021 August; 40 (8):4888-4892 10.1016/j.clnu.2021.06.026
Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)
Journal of Clinical Oncology, 2021. 39(15_suppl): p. 4090-4090.. 2021 June;
Damaraju V.L., Aminpour M., Kuzma M., Winter P., Preto J., Tuszynski J., McEwan A.B.J., Sawyer M.B.
CTS-Clinical and Translational Science. 2021 May; 14 (3):847-858 10.1111/cts.12943
Youn S., Reif R., Chu M.P., Smylie M., Walker J., Eurich D.T., Ghosh S., Sawyer M.B.
EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2021 April; 42 10.1016/j.clnesp.2021.01.009
Sarcopenia predicts dose-limiting toxicity in pancreatic cancer treated with nab-paclitaxel and gemcitabine
American Association of Cancer Researchers Annual Meeting 2021. 2021 April;
Giani J., Sawyer M.B., Chambers C.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021 March; 27 (2):447-479 10.1177/1078155220934163
Nath E., Sawyer M.B., Choy J.
Case Reports in Oncology. 2021 January; 13 (3):1454-1462 10.1159/000511414
Ford K.L., Sawyer M.B., Trottier C.F., Ghosh S., Deutz N.E.P., Siervo M., Porter Starr K.N., Bales C.W., Disi I.R., Prado C.M.
Clinical Nutrition ESPEN. 2021 January; 41 10.1016/j.clnesp.2020.11.016
Sarcopenia predicts dose-limiting toxicity in pancreatic cancer treated with nab-paclitaxel and gemcitabine
13th international SCWD digital conference on cachexia, sarcopenia and muscle wasting. 2020 December;
van der Meij B.S., Teleni L., Stanislaus A.E., Murphy R.A., Robinson L., Damaraju V.L., Chu Q., Sawyer M.B., Mazurak V.
Clinical Nutrition ESPEN. 2020 November; 40 10.1016/j.clnesp.2020.09.009